statistiche ricercatore

Continente	#
NA - Nord America	1.224
EU - Europa	958
AS - Asia	438
SA - Sud America	64
AF - Africa	21
Continente sconosciuto - Info sul continente non disponibili	16
OC - Oceania	1
Totale	2.722

Nazione	#
US - Stati Uniti d'America	1.206
RU - Federazione Russa	242
CN - Cina	188
GB - Regno Unito	183
SG - Singapore	126
IE - Irlanda	119
IT - Italia	84
SE - Svezia	72
DE - Germania	71
UA - Ucraina	62
FR - Francia	51
BR - Brasile	50
VN - Vietnam	37
HK - Hong Kong	35
FI - Finlandia	28
IN - India	15
CA - Canada	12
ES - Italia	12
ZA - Sudafrica	12
KR - Corea	10
CZ - Repubblica Ceca	8
NL - Olanda	7
AR - Argentina	6
BD - Bangladesh	6
BE - Belgio	6
PL - Polonia	5
IQ - Iraq	4
MX - Messico	4
TR - Turchia	4
CL - Cile	3
LT - Lituania	3
NG - Nigeria	3
AE - Emirati Arabi Uniti	2
AT - Austria	2
DZ - Algeria	2
EC - Ecuador	2
ID - Indonesia	2
IR - Iran	2
LB - Libano	2
VE - Venezuela	2
AL - Albania	1
AU - Australia	1
AZ - Azerbaigian	1
CH - Svizzera	1
DK - Danimarca	1
HN - Honduras	1
KE - Kenya	1
KZ - Kazakistan	1
LA - Repubblica Popolare Democratica del Laos	1
MA - Marocco	1
MZ - Mozambico	1
PH - Filippine	1
RE - Reunion	1
TT - Trinidad e Tobago	1
UY - Uruguay	1
UZ - Uzbekistan	1
Totale	2.706

Nome	#
Effect of ligand binding on human D-amino acid oxidase: implications for the development of new drugs for schizophrenia treatment	363
Gene-expression analysis identifies novel RBL2/p130 target genes in endemic Burkitt lymphoma cell lines and primary tumors.	313
Cellular kinetic differences between Hodgkin's and anaplastic large cell lymphomas: relation to the expression of p34cdc2 and cyclin B-1	274
Gene expression analysis uncovers similarity and differences among Burkitt lymphoma subtypes	259
Dendrimeric peptide inhibitors of anthrax lethal and edema factors	239
Anaplastic large cell lymphomas and Hodkin’s disease: distinctive growth features and expression of p34cdc2/cyclin B-1	239
The alteration of lipid metabolism in Burkitt lymphoma identifies a novel marker: Adipophilin	233
Branched Neurotensin peptides for tumor personalized therapy	231
Tumor selective targeting by branched peptides	210
Characterization of the branched antimicrobial peptide M6 by analyzing its mechanism of action and in vivo toxicity.	189
Expression of p34(cdc2) and cyclin B-1 in Hodgkin's disease and anaplastic large cell lymphomas	172
Totale	2.722

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	127	0	14	11	11	7	5	5	10	6	13	12	33
2022/2023	245	13	28	31	29	32	38	5	18	25	13	12	1
2023/2024	213	7	6	30	7	12	63	65	1	1	6	0	15
2024/2025	302	7	16	51	19	43	13	0	15	15	10	33	80
2025/2026	852	46	102	79	130	210	34	88	23	17	46	17	60
2026/2027	39	20	19	0	0	0	0	0	0	0	0	0	0
Totale													2.722